INTRODUCTION Lung cancer is one of the cancers with the highest morbidity and mortality worldwide.Over the two past decades,although the treatment of non-small cell lung cancer(NSCLC)has been revolutionized by the use...INTRODUCTION Lung cancer is one of the cancers with the highest morbidity and mortality worldwide.Over the two past decades,although the treatment of non-small cell lung cancer(NSCLC)has been revolutionized by the use of tyrosine kinase inhibitor(TKI)and immune treatments,metastatic disease remains largely incurable and presents a 5-year survival rate of approximately 10%[1].展开更多
基金This work was supported by the Zhongshan City People’s Hospital Major Project(Top Youth Program)(Grant No.B2021003)Project of National Natural Science Foundation(Grant No.81872510)+3 种基金High-Level Hospital Construction Project(Grant No.DFJH201801)Guangdong Provincial People’s Hospital Young Talent Project(Grant No.GDPPHYTP201902)GDPH Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province(Grant No.KJ012019449)Guangdong Basic and Applied Basic Research Foundation(No.2019B1515130002).
文摘INTRODUCTION Lung cancer is one of the cancers with the highest morbidity and mortality worldwide.Over the two past decades,although the treatment of non-small cell lung cancer(NSCLC)has been revolutionized by the use of tyrosine kinase inhibitor(TKI)and immune treatments,metastatic disease remains largely incurable and presents a 5-year survival rate of approximately 10%[1].
